Journal article

Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties

A Hoang, AJ Murphy, MT Coughlan, MC Thomas, JM Forbes, R O'Brien, ME Cooper, JPF Chin-Dusting, D Sviridov

DIABETOLOGIA | SPRINGER | Published : 2007


AIMS/HYPOTHESIS: AGE contribute to the pathogenesis of diabetic complications, including dyslipidaemia and atherosclerosis. However, the precise mechanisms remain to be established. In the present study, we examined whether AGE modification of apolipoprotein A-I (apoA-I) affects its functionality, thus altering its cardioprotective profile. MATERIALS AND METHODS: The ability of AGE-modified apoA-I to facilitate cholesterol and phospholipid efflux, stabilise ATP-binding cassette transporter A1 (ABCA1) and inhibit expression of adhesion molecules in human macrophages and monocytes was studied. RESULTS: The ability of AGE-modified apoA-I to promote cholesterol efflux from THP-1 macrophages, iso..

View full abstract

University of Melbourne Researchers